Total Payments
$42,134
2024 Payments
$1,559
Companies
69
Transactions
934
Medicare Patients
3,187
Medicare Billing
$216,460
Payment Breakdown by Category
Other$18,830 (44.7%)
Food & Beverage$16,332 (38.8%)
Travel$4,094 (9.7%)
Consulting$2,814 (6.7%)
Education$64.23 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $18,330 | 9 | 43.5% |
| Food and Beverage | $16,332 | 905 | 38.8% |
| Travel and Lodging | $4,094 | 7 | 9.7% |
| Consulting Fee | $2,814 | 4 | 6.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $500.00 | 1 | 1.2% |
| Education | $64.23 | 8 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Orexigen Therapeutics, Inc. | $20,452 | 36 | $0 (2018) |
| Novo Nordisk Inc | $3,622 | 171 | $0 (2024) |
| US WorldMeds, LLC | $3,011 | 5 | $0 (2018) |
| Currax Pharmaceuticals LLC | $2,634 | 15 | $0 (2023) |
| ABBVIE INC. | $2,162 | 126 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $1,231 | 87 | $0 (2023) |
| Lilly USA, LLC | $799.05 | 45 | $0 (2024) |
| Amarin Pharma Inc. | $728.60 | 13 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $693.39 | 32 | $0 (2024) |
| Abbott Laboratories | $479.73 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,559 | 73 | ABBVIE INC. ($443.68) |
| 2023 | $2,032 | 86 | AbbVie Inc. ($927.75) |
| 2022 | $2,451 | 110 | Novo Nordisk Inc ($617.57) |
| 2021 | $3,338 | 62 | Currax Pharmaceuticals LLC ($2,558) |
| 2020 | $1,094 | 80 | Novo Nordisk Inc ($287.15) |
| 2019 | $2,792 | 149 | Novo Nordisk Inc ($1,079) |
| 2018 | $5,722 | 168 | US WorldMeds, LLC ($3,011) |
| 2017 | $23,148 | 206 | Orexigen Therapeutics, Inc. ($20,437) |
All Payment Transactions
934 individual payment records from CMS Open Payments — Page 2 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Diabetes | ||||||
| 07/03/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 06/28/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Obesity | ||||||
| 06/26/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Diabetes | ||||||
| 06/25/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: VACCINES | ||||||
| 06/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: ADHD | ||||||
| 06/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Diabetes | ||||||
| 06/11/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: PAIN | ||||||
| 06/04/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Endocrinology | ||||||
| 05/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $98.93 | General |
| Category: Obesity | ||||||
| 05/29/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/22/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Diabetes | ||||||
| 05/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Diabetes | ||||||
| 05/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Biological | ||||||
| 04/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: NEUROSCIENCE | ||||||
| 04/23/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 04/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Diabetes | ||||||
| 04/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Education | In-kind items and services | $15.06 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $65.20 | General |
| Category: Endocrinology | ||||||
| 04/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 613 | 913 | $152,837 | $47,761 |
| 2022 | 14 | 662 | 997 | $152,635 | $48,916 |
| 2021 | 19 | 1,206 | 1,604 | $202,055 | $69,475 |
| 2020 | 13 | 706 | 1,169 | $165,711 | $50,308 |
Total Patients
3,187
Total Services
4,683
Medicare Billing
$216,460
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 188 | 402 | $105,477 | $30,456 | 28.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 82 | 82 | $23,384 | $9,221 | 39.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 40 | $7,102 | $2,131 | 30.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 45 | 45 | $2,233 | $1,328 | 59.5% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 72 | 72 | $3,212 | $1,152 | 35.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 68 | 68 | $2,976 | $1,088 | 36.6% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 49 | 49 | $2,450 | $1,072 | 43.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 76 | $3,772 | $666.40 | 17.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 32 | 51 | $1,376 | $485.52 | 35.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 14 | $574.84 | $129.87 | 22.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 12 | 14 | $280.00 | $30.80 | 11.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 149 | 323 | $84,749 | $25,282 | 29.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 63 | 63 | $17,966 | $7,247 | 40.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 52 | 64 | $11,363 | $3,505 | 30.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 21 | 25 | $8,852 | $2,918 | 33.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 33 | 53 | $5,448 | $1,784 | 32.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 55 | 58 | $2,879 | $1,648 | 57.3% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 55 | 58 | $2,900 | $1,221 | 42.1% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 66 | 66 | $2,944 | $1,086 | 36.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 20 | 104 | $5,162 | $967.20 | 18.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 20 | 22 | $2,750 | $953.98 | 34.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 58 | 58 | $2,539 | $936.56 | 36.9% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 18 | 18 | $2,916 | $683.82 | 23.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 39 | 67 | $1,808 | $642.77 | 35.6% |
| 81003 | Automated urinalysis test | Office | 2022 | 13 | 18 | $360.00 | $39.93 | 11.1% |
About Dr. Stephanie Berg, MD
Dr. Stephanie Berg, MD is a Internal Medicine healthcare provider based in Frisco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629047659.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephanie Berg, MD has received a total of $42,134 in payments from pharmaceutical and medical device companies, with $1,559 received in 2024. These payments were reported across 934 transactions from 69 companies. The most common payment nature is "Honoraria" ($18,330).
As a Medicare-enrolled provider, Berg has provided services to 3,187 Medicare beneficiaries, totaling 4,683 services with total Medicare billing of $216,460. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Obesity Medicine, Internal Medicine
- Location Frisco, TX
- Active Since 03/14/2006
- Last Updated 07/15/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1629047659
Products in Payments
- CONTRAVE (Drug) $23,122
- Lucemyra/Lofexidine (Drug) $3,011
- VRAYLAR (Drug) $1,321
- Ozempic (Drug) $1,212
- TROKENDI XR (Drug) $931.68
- Saxenda (Drug) $856.78
- Vascepa (Drug) $728.60
- FARXIGA (Drug) $576.57
- UBRELVY (Drug) $538.35
- JARDIANCE (Drug) $440.34
- MOUNJARO (Drug) $389.68
- Tresiba (Drug) $342.72
- Victoza (Drug) $333.30
- QULIPTA (Drug) $298.69
- NASCOBAL (Drug) $282.75
- Wegovy (Drug) $268.19
- Rybelsus (Drug) $234.97
- NURTEC ODT (Drug) $228.88
- QSYMIA (Drug) $222.10
- JANUVIA (Drug) $211.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Frisco
Jasbir Dhawan, Md, MD
Internal Medicine — Payments: $320,303
Internal Medicine $320,303
Jason Riehs, Md, MD
Internal Medicine — Payments: $201,897
Internal Medicine $201,897
Dr. Naveen Sikka, M.d, M.D
Internal Medicine — Payments: $96,322
Internal Medicine $96,322
Dr. Sibi Thomas, D.o, D.O
Internal Medicine — Payments: $75,591
Internal Medicine $75,591
Ramesh Amara, Md, MD
Internal Medicine — Payments: $13,128
Internal Medicine $13,128
John Treer, Md, MD
Internal Medicine — Payments: $11,539
Internal Medicine $11,539